Celcuity Inc. (CELC)
CELC trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$63.19
-4.04% on the day
Market cap
$3.1B
Mid cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CELC on Nasdaq |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | 2017 |
| SEC CIK | 0001603454 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-05 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-02 |
| Latest proxy | DEFA14A | 2026-04-02 |
Source: SEC EDGAR submissions feed, 540 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -9.5% |
| 1 month | -28.0% |
| 3 months | -32.6% |
| Year to date | -40.3% |
| 1 year | +25.6% |
| From 52-week high | -58.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CDNA | CareDx Inc. | $65.43 | +3.66% | $3.4B |
| ACHC | Acadia Healthcare Company Inc. | $30.23 | +0.50% | $2.8B |
| VCYT | Veracyte Inc. | $43.11 | -2.07% | $3.5B |
| CLOV | Clover Health Investments Corp. | $4.81 | +0.63% | $2.6B |
| BLLN | BillionToOne Inc. | $94.44 | +1.47% | $4.5B |
| CON | Concentra Group Holdings Parent Inc. | $37.54 | 0.00% | $4.8B |
| FTRE | Fortrea Holdings Inc. | $20.92 | -0.38% | $2.0B |
| ALHC | Alignment Healthcare Inc. | $8.30 | +2.60% | $1.7B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier